Skip to search formSkip to main contentSkip to account menu

telcagepant

Known as: N-((3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)hexahydro-1h-azepin-3- yl)-4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
CGRP is a potent vasodilator and nociceptive neuropeptide linked to migraine. CGRP receptors are heterodimers of receptor… 
2016
2016
This issue of Cephalalgia contains what is likely to be one of the last reports of a clinical trial of telcagepant (1… 
2013
2013
Objective The objective of this article is to assess the effects of sumatriptan monotherapy, telcagepant monotherapy, and their… 
Highly Cited
2012
Highly Cited
2012
Objective.— To evaluate the efficacy of telcagepant in patients with migraine and coronary artery disease. 
Review
2011
Review
2011
Telcagepant (MK0974) is one of several calcitonin-gene-related peptide antagonists in development as a potential treatment for… 
Highly Cited
2010
Highly Cited
2010
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Calcitonin gene-related peptide (CGRP) was first described as a potent vasodilator… 
Highly Cited
2010
Highly Cited
2010
Methods: This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for…